gross profit bridgeinconsistent2021-12-31
Withheld: gross profit could not be reconciled with the rest of this filer’s statement.
Revenue
$3.18B
Fiscal year ended 2025-12-31Operating income
$78.52M
Fiscal year ended 2025-12-31Free cash flow
$104.49M
Fiscal year ended 2025-12-31Astrana Health, Inc. (ASTH) reported revenue of $3.18B and net income of $22.49M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Astrana Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Management Consulting Services.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.18B | $2.03B | $1.39B | $1.14B | $773.92M | $687.18M | $560.62M | $519.91M | $356.36M | $57.43M |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | $596.14M | $539.21M | $467.80M | $361.13M | $273.45M | Unavailable |
| Gross profit | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $92.81M | $158.78M | $82.90M | Unavailable |
| Operating income | $78.52M | $89.35M | $84.61M | $104.26M | $98.18M | $80.50M | $32.42M | $88.43M | $35.15M | -$10.54M |
| Net income | $22.49M | $43.15M | $60.72M | $45.17M | $68.92M | $37.69M | $14.12M | $10.84M | $25.80M | -$8.97M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 49.37M | shares 47.97M | shares 46.94M | shares 45.60M | shares 45.40M | shares 37.45M | shares 36.40M | shares 37.91M | shares 28.66M | Unavailable |
| Pretax income | $39.61M | $80.82M | $89.84M | $86.62M | $77.75M | $178.43M | $25.84M | $82.63M | $49.71M | -$8.73M |
| Income tax expense | $15.53M | $30.89M | $31.99M | $40.88M | $31.69M | $56.34M | $8.17M | $22.36M | $3.89M | -$47.50K |
| Diluted EPS | $0.46 | $0.90 | $1.29 | $0.99 | $1.52 | $1.01 | $0.39 | $0.29 | $0.90 | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| General & administrative | $217.26M | $154.11M | $112.60M | $77.67M | $62.08M | $49.12M | $41.48M | $43.35M | $26.25M | $18.58M |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $429.47M | $288.46M | $293.81M | $288.03M | $233.10M | $193.47M | $103.19M | $106.89M | $99.75M | $63.25M |
| Total assets | $2.22B | $1.35B | $933.36M | $966.21M | $867.36M | $817.49M | $728.71M | $513.00M | $490.64M | $20.64M |
| Current assets | $863.31M | $638.50M | $461.51M | $428.12M | $404.46M | $338.58M | $329.07M | $172.86M | $144.16M | $14.92M |
| Total liabilities | $1.66B | $840.73M | $522.59M | $407.67M | $356.72M | $372.34M | $367.65M | $106.34M | $154.32M | $20.37M |
| Current liabilities | $615.27M | $365.61M | $218.67M | $148.61M | $114.72M | $114.99M | $105.42M | $72.02M | $109.60M | $14.54M |
| Total equity incl. NCI | $793.30M | $716.73M | $616.65M | $544.31M | $454.11M | $329.46M | $192.34M | $181.54M | $164.18M | $270.37K |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | $14.24M | $56.54M | $113.57M | $168.72M | $225.12M | $172.13M | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $374.46M | $275.99M | Unavailable | $49.63M | $10.61M | $7.06M | $11.00M | $7.73M | $7.60M | $5.51M |
| Goodwill | $865.30M | $419.25M | $278.83M | $269.05M | $246.42M | $232.43M | $238.50M | $185.81M | $189.85M | $1.62M |
| Long-term debt | $990.90M | $425.30M | $258.94M | $203.39M | $182.92M | $230.21M | $232.17M | $0 | Unavailable | Unavailable |
| Accounts payable | Unavailable | Unavailable | Unavailable | Unavailable | $9.58M | $9.55M | $6.91M | $4.48M | $3.79M | Unavailable |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $114.60M | $52.20M | $68.23M | $82.13M | $70.34M | $46.16M | $13.67M | $25.50M | $51.83M | Unavailable |
| Capital expenditures | $10.11M | $8.03M | $28.53M | $22.94M | $19.22M | $1.16M | $1.04M | $1.17M | $2.08M | $297.56K |
| Investing cash flow | -$539.00M | -$192.40M | -$65.52M | -$7.11M | $16.54M | $95.49M | -$180.63M | -$25.18M | $26.72M | Unavailable |
| Financing cash flow | $569.35M | $135.15M | $3.42M | -$20.08M | -$47.75M | -$51.70M | $163.33M | -$11.18M | -$14.98M | Unavailable |
| Net change in cash | $144.94M | -$5.05M | $6.12M | $54.93M | $39.13M | $89.96M | -$3.63M | -$10.86M | $63.57M | -$605.80K |
| Stock-based compensation | $38.60M | $34.54M | $22.04M | $16.10M | $6.74M | $3.38M | $1.55M | $1.44M | $2.74M | Unavailable |
| Common dividends paid | $7.88M | $4.04M | $62.07M | $14.03M | $31.09M | $51.32M | $61.72M | $17.76M | $10.45M | Unavailable |
| Common share repurchases | $25.60M | $900.00K | $10.19M | $9.25M | $5.74M | $537.00K | $7.57M | $5.05M | $3.18M | Unavailable |
| Depreciation & amortization | $45.75M | $27.93M | $17.75M | $17.54M | $17.52M | $18.35M | $18.28M | $19.30M | $19.08M | $645.74K |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $104.49M | $44.17M | $39.70M | $59.19M | $51.11M | $45.00M | $12.63M | $24.33M | $49.75M | Unavailable |
| Gross margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 16.6% | 30.5% | 23.3% | Unavailable |
| Operating margin | 2.5% | 4.4% | 6.1% | 9.1% | 12.7% | 11.7% | 5.8% | 17.0% | 9.9% | -18.3% |
| FCF margin | 3.3% | 2.2% | 2.9% | 5.2% | 6.6% | 6.5% | 2.3% | 4.7% | 14.0% | Unavailable |
| SBC / revenue | 1.2% | 1.7% | 1.6% | 1.4% | 0.9% | 0.5% | 0.3% | 0.3% | 0.8% | Unavailable |
| Current ratio | 1.40x | 1.75x | 2.11x | 2.88x | 3.53x | 2.94x | 3.12x | 2.40x | 1.32x | 1.03x |
| Revenue YoY growth | 56.4% | 46.7% | 21.2% | 47.8% | 12.6% | 22.6% | 7.8% | 45.9% | Unavailable | Unavailable |
| Net margin | 0.7% | 2.1% | 4.4% | 3.9% | 8.9% | 5.5% | 2.5% | 2.1% | 7.2% | -15.6% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 0.3% | 0.4% | 2.1% | 2.0% | 2.5% | 0.2% | 0.2% | 0.2% | 0.6% | 0.5% |
| Long-term debt / equity | 1.25x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 39.2% | 38.2% | 35.6% | 47.2% | 40.8% | 31.6% | 31.6% | 27.1% | 7.8% | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ASTH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-08View SEC filing
10-K · Filed 2026-03-12View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-09View SEC filing
Reconciliation checks needing review
6 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2020-12-31
Withheld: gross profit could not be reconciled with the rest of this filer’s statement.
balance equationreview2025-12-31
Difference 234962000 exceeds tolerance 2218661.000. Presentation or filing-vintage differences need review.
balance equationreview2024-12-31
Difference 202558000 exceeds tolerance 1354894.000. Presentation or filing-vintage differences need review.
balance equationreview2023-12-31
Difference 205883000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2020-12-31
Difference 2119000 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.